NOVO.B.DK

315.4

+1.59%↑

GMAB.DK

2,047

+0.79%↑

HLUNB.DK

44.54

+1.14%↑

ZEAL.DK

518

-1.86%↓

NOVO.B.DK

315.4

+1.59%↑

GMAB.DK

2,047

+0.79%↑

HLUNB.DK

44.54

+1.14%↑

ZEAL.DK

518

-1.86%↓

NOVO.B.DK

315.4

+1.59%↑

GMAB.DK

2,047

+0.79%↑

HLUNB.DK

44.54

+1.14%↑

ZEAL.DK

518

-1.86%↓

NOVO.B.DK

315.4

+1.59%↑

GMAB.DK

2,047

+0.79%↑

HLUNB.DK

44.54

+1.14%↑

ZEAL.DK

518

-1.86%↓

NOVO.B.DK

315.4

+1.59%↑

GMAB.DK

2,047

+0.79%↑

HLUNB.DK

44.54

+1.14%↑

ZEAL.DK

518

-1.86%↓

Search

Coloplast A-S (Class B)

Închisă

583.8 -0.07

Rezumat

Modificarea prețului

24h

Curent

Minim

583.4

Maxim

585

Indicatori cheie

By Trading Economics

Venit

-107M

805M

Vânzări

28M

7B

P/E

Medie Sector

35.851

79.874

EPS

4.67

Randament dividend

3.96

Marjă de profit

11.569

Angajați

16,744

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

3.96%

2.31%

Statistici piață

By TradingEconomics

Capitalizare de piață

-6.4B

130B

Deschiderea anterioară

583.87

Închiderea anterioară

583.8

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 nov. 2025, 15:29 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

28 nov. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

28 nov. 2025, 19:59 UTC

Market Talk

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

28 nov. 2025, 19:47 UTC

Market Talk

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

28 nov. 2025, 18:16 UTC

Market Talk

Global Equities Roundup: Market Talk

28 nov. 2025, 18:16 UTC

Market Talk

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov. 2025, 18:08 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

28 nov. 2025, 18:08 UTC

Market Talk

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov. 2025, 17:48 UTC

Market Talk

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

28 nov. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

28 nov. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

28 nov. 2025, 15:51 UTC

Market Talk

Canada Household Spending Edges Lower -- Market Talk

28 nov. 2025, 15:33 UTC

Market Talk

Crude Futures Gain as U.S. Market Reopens -- Market Talk

28 nov. 2025, 15:21 UTC

Market Talk

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

28 nov. 2025, 15:13 UTC

Market Talk

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

28 nov. 2025, 15:11 UTC

Market Talk

Global Equities Roundup: Market Talk

28 nov. 2025, 15:11 UTC

Market Talk

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

28 nov. 2025, 14:51 UTC

Market Talk

Canada GDP Report Masks Fragile State of Economy -- Market Talk

28 nov. 2025, 14:41 UTC

Market Talk

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

28 nov. 2025, 14:37 UTC

Market Talk

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

28 nov. 2025, 14:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 nov. 2025, 14:33 UTC

Market Talk

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

28 nov. 2025, 14:20 UTC

Market Talk

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

28 nov. 2025, 14:10 UTC

Market Talk

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

28 nov. 2025, 13:39 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 nov. 2025, 13:39 UTC

Market Talk

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

28 nov. 2025, 13:36 UTC

Market Talk

Canada's Economy Expands More Than Expected -- Market Talk

28 nov. 2025, 13:29 UTC

Market Talk

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

28 nov. 2025, 13:27 UTC

Market Talk

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

28 nov. 2025, 13:19 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat